Table 2 Comparison of Tumor Clinicopathology and Radiolographic nodal status between patients with Pathological nodal status N1 and Pathological nodal status N0
| Â | Total | No. of Patient with Pathological node N1 | No. of Patient with Pathological node N0 | p-value |
|---|---|---|---|---|
Location | Â | Â | Â | 0.189 |
 Right | 108 | 9 (8.4%) | 99 (91.6%) |  |
 Left | 131 | 18 (13.8%) | 113 (86.2%) |  |
Tumor size | Â | Â | Â | 0.095 |
 T1 (< 2 cm) | 150 | 13 (11.9%) | 133 (91.1%) |  |
 T2 (2–5 cm) | 89 | 14 (14.8%) | 75 (85.2%) |  |
Radiolographic node |  < 0.001* | |||
 Borderline | 20 | 11 (55.0%) | 9 (45.0%) |  |
 Negative | 219 | 16 (7.4%) | 203 (92.6%) |  |
Histologic grade | Â | Â | Â | 0.079 |
 1 | 48 | 1 (2.1%) | 47 (97.9%) |  |
 2 | 132 | 18 (13.7%) | 114 (86.3%) |  |
 3 | 59 | 8 (13.6%) | 51 (86.4%) |  |
Histopathology | Â | Â | Â | 0.333 |
 IDC | 195 | 27 (13.9%) | 168 (86.1%) |  |
 ILC | 9 | 0 (0%) | 9 (100%) |  |
 DCISM | 15 | 0 (0%) | 15 (100%) |  |
 Mucinous | 10 | 0 (0%) | 10 (100%) |  |
 Papillary | 6 | 0 (0%) | 6 (100%) |  |
 Tubular | 1 | 0 (0%) | 1 (100%) |  |
 Mixed | 3 | 0 (0%) | 3 (100%) |  |
Lymphovascular invasion |  < 0.001* | |||
 Yes | 39 | 18 (46.2%) | 21 (53.8%) |  |
 No | 200 | 9 (4.5%) | 191 (95.5%) |  |
Estrogen receptor | Â | Â | Â | 0.961 |
 Positive | 185 | 21 (11.4%) | 164 (88.6%) |  |
 Negative | 54 | 6 (11.1%) | 48 (88.9%) |  |
Progesterone receptor | 0.834 | |||
 Positive | 155 | 18 (11.7%) | 137 (88.3%) |  |
 Negative | 84 | 9 (10.8%) | 75 (89.2%) |  |
HER-2 | Â | Â | Â | 0.967 |
 Positive | 49 | 6 (12.2%) | 43 (87.8%) |  |
 Negative | 180 | 20 (11.1%) | 160 (88.9%) |  |
 Not known | 10 | 1 (10.0%) | 9 (90.0%) |  |
 Total | 239 | 27 | 212 |  |